机构:[1]Moorfields Eye Hosp NHS Fdn Trust, London, England[2]Beijing Tongren Hosp, Beijing, Peoples R China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[3]Capital Med Univ, Beijing, Peoples R China[4]Beijing Inst Ophthalmol, Beijing, Peoples R China研究所眼科研究所首都医科大学附属北京同仁医院首都医科大学附属同仁医院[5]Univ Nottingham, Acad Ophthalmol, Nottingham, England[6]Keye Eye Ctr, Seoul, South Korea[7]Univ Illinois, Chicago, IL USA[8]Med Coll Wisconsin, Milwaukee, WI 53226 USA[9]Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London, England[10]UCL Inst Ophthalmol, London, England研究所眼科研究所首都医科大学附属北京同仁医院[11]Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China[12]Peking Union Med Coll Hosp, Beijing, Peoples R China[13]Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima, Japan[14]Tel Aviv Med Ctr & Sch Med, Dept Ophthalmol, Tel Aviv, Israel[15]C Mer Int Eye Care Grp Ltd, C MER Dennis Lam Eye Ctr, Hong Kong, Peoples R China[16]Chinese Univ Hong Kong Shenzhen, Int Eye Res Inst, Shenzhen, Peoples R China[17]Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY 10029 USA[18]Duke NUS Med Sch Singapore, Singapore Natl Eye Ctr, Singapore, Singapore[19]Univ Southern Calif, Keck Sch Med, USC Roski Eye Inst, Los Angeles, CA 90007 USA
The simultaneous maturation of multiple digital and telecommunications technologies in 2020 has created an unprecedented opportunity for ophthalmology to adapt to new models of care using tele-health supported by digital innovations. These digital innovations include artificial intelligence (AI), 5th generation (5G) telecommunication networks and the Internet of Things (IoT), creating an inter-dependent ecosystem offering opportunities to develop new models of eye care addressing the challenges of COVID-19 and beyond. Ophthalmology has thrived in some of these areas partly due to its many image-based investigations. Tele-health and AI provide synchronous solutions to challenges facing ophthalmologists and healthcare providers worldwide. This article reviews how countries across the world have utilised these digital innovations to tackle diabetic retinopathy, retinopathy of prematurity, age-related macular degeneration, glaucoma, refractive error correction, cataract and other anterior segment disorders. The review summarises the digital strategies that countries are developing and discusses technologies that may increasingly enter the clinical workflow and processes of ophthalmologists. Furthermore as countries around the world have initiated a series of escalating containment and mitigation measures during the COVID-19 pandemic, the delivery of eye care services globally has been significantly impacted. As ophthalmic services adapt and form a "new normal", the rapid adoption of some of telehealth and digital innovation during the pandemic is also discussed. Finally, challenges for validation and clinical implementation are considered, as well as recommendations on future directions.
Li Ji-Peng Olivia,Liu Hanruo,Ting Darren S. J.,et al.Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective[J].PROGRESS IN RETINAL AND EYE RESEARCH.2021,82:doi:10.1016/j.preteyeres.2020.100900.
APA:
Li, Ji-Peng Olivia,Liu, Hanruo,Ting, Darren S. J.,Jeon, Sohee,Chan, R. V. Paul...&Ting, Daniel S. W..(2021).Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective.PROGRESS IN RETINAL AND EYE RESEARCH,82,
MLA:
Li, Ji-Peng Olivia,et al."Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective".PROGRESS IN RETINAL AND EYE RESEARCH 82.(2021)